NSEGeneral Updates3d ago · 3 Sept 2026, 12:20 pm

General Updates

Shukra Pharmaceuticals Limited · SHUKRAPHAR

✦ AI SummaryDividend

Shukra Pharmaceuticals Limited has informed the Exchange about General Updates, specifically the Record Date for determining eligibility for Final Dividend for the financial year ended 31 March, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

Attachments (1)

📄

SHUKRA_03092026122008_Shukra_Record_Date_Dividend_Intimation.pdf

pdf

Download →
View document text
September 03, 2026 The Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited Ground Floor, P. J. Tower, Exchange Plaza, 5 Floor Plot No. C/1, Dalal Street, G. Block Bandra-Kurla Complex, Mumbai-400001 Bandra (E), Mumbai - 400 051 Scrip Code: 524632 NSE Symbol: SHUKRAPHAR Sub: Intimation of Record Date for determining eligibility for Final Dividend pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform you that the Company has fixed Monday, September 21, 2026 as the Record Date for determining the eligibility of members entitled to receive the Final Dividend of % 0.01/- per equity share of face value of X 1/- each for the financial year ended 31 March, 2026, subject to declaration of the said Final Dividend by the members of the Company at the ensuing 33 Annual General Meeting (“AGM”). The details are as follows: Security Code | Type of Record Date | Purpose Final Annual / Symbol Security Dividend General proposed Meeting 524632/ Equity Share | Monday, 21" | Determining | X 0.01/- per | 33 AGM to SHUKRAPHAR September, | the eligibility | equity share | be held on 2026 of members | of face value | Monday, entited to | of X 1/- each | September receive Final 28,2026 Dividend for FY 2025-26 The Final Dividend is subject to approval of the members at the ensuing AGM. Upon declaration of the Final Dividend, the same shall be paid to those members whose names appear in the Register of Members of the Company or in the records of the Depositories, as applicable, as on the aforesaid Record Date. CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com The Final Dividend, if declared at the AGM, shall be paid within ays from the date of declaration, in accordance with the applicable provisions of the Companies Act, 2013, In accordance with Regulation 42 of the SEBI LODR Regulations, the Record Date has been fixed after giving the requisite advance notice to the Stock Exchange(s). The above information is being furnished for your information and record. Thanking you, Yours faithfully, For Shukra Pharmaceuticals Limited, Name: Shivkant Dhakad Designation: Company Secretary-cum-Compliance Officer Membership No.: A80894 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, I_ndia, Ph. :02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com